# BlossomHill Therapeutics, (BLSM) — Analyst Forecast

BLSM · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/blsm/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 5 | 0 | 0 | 5 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $28.00 | $35.00 | $40.00 | 5 |

Last price $14.98 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 21, 2026 | Leerink Partners | Maintained | Outperform | $40.00 |
| Sep 21, 2026 | Guggenheim | Maintained | Buy | $40.00 |
| Sep 1, 2026 | JP Morgan | Initiated Coverage | Overweight | $28.00 |
| Sep 1, 2026 | Guggenheim | Initiated Coverage | Buy | $30.00 |
| Sep 1, 2026 | HC Wainwright & Co. | Initiated Coverage | Buy | $35.00 |
| Sep 1, 2026 | LifeSci Capital | Initiated Coverage | Outperform | $32.00 |
| Sep 1, 2026 | Leerink Partners | Initiated Coverage | Outperform | $36.00 |

## Frequently Asked Questions

### What is the price target for BLSM stock?

The average 12-month analyst price target for BlossomHill Therapeutics, (BLSM) is $35.00, with a high estimate of $40.00 and a low of $28.00, across 5 analysts.

### Is BLSM a buy, sell, or hold?

Analysts covering BlossomHill Therapeutics, currently average a Buy rating: 5 buy, 0 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for BLSM?

The average price target of $35.00 implies 133.64% upside from the last price of $14.98.

### What is the latest analyst rating on BLSM?

On Sep 21, 2026, Leerink Partners maintained BlossomHill Therapeutics, at Outperform with a price target of $40.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).